Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Carta

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Bioorganic & Medicinal Chemistry|February 26, 2018
Targeting RORs nuclear receptors by novel synthetic steroidal inverse agonists for autoimmune disordersMatteo Dal Prà, Davide Carta, Gyorgy Szabadkai, et al.
Biochemical Pharmacology|July 15, 2018
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cellsElena Mariotto, Roberta Bortolozzi, Ilaria Volpin, et al.
European Journal of Medicinal Chemistry|November 9, 2016
Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agentsDavide Carta, Roberta Bortolozzi, Mattia Sturlese, et al.
Journal of Medicinal Chemistry|September 13, 2013
Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitorsMaria Grazia Ferlin, Davide Carta, Roberta Bortolozzi, et al.
Nuclear Medicine and Biology|October 4, 2016
Melanoma targeting with [<sup>99m</sup>Tc(N)(PNP3)]-labeled α-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical propertiesDavide Carta, Nicola Salvarese, Nicolò Morellato, et al.
Frontiers in Immunology|January 30, 2020
Pyridinecarboxylic Acid Derivative Stimulates Pro-Angiogenic Mediators by PI3K/AKT/mTOR and Inhibits Reactive Nitrogen and Oxygen Species and NF-κB Activation Through a PPARγ-Dependent Pathway in <i>T. cruzi</i>-Infected MacrophagesFederico Nicolás Penas, Davide Carta, Ágata Carolina Cevey, et al.
Amino Acids|December 9, 2015
Radiopharmacological characterization of ⁶⁴Cu-labeled α-MSH analogs for potential use in imaging of malignant melanomaFeng Gao, Wiebke Sihver, Christoph Jurischka, et al.
Analytical Chemistry|July 6, 2011
Method for optimizing coating properties based on an evolutionary algorithm approachDavide Carta, Laura Villanova, Stefano Costacurta, et al.
Frontiers in Immunology|January 10, 2018
Treatment with a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of <i>Trypanosoma cruzi</i>-Infected MiceFederico Nicolás Penas, Davide Carta, Ganna Dmytrenko, et al.
European Journal of Medicinal Chemistry|June 14, 2019
Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinonesRoberta Bortolozzi, Davide Carta, Matteo Dal Prà, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Bioorganic & Medicinal Chemistry|February 26, 2018
Targeting RORs nuclear receptors by novel synthetic steroidal inverse agonists for autoimmune disordersMatteo Dal Prà, Davide Carta, Gyorgy Szabadkai, et al.
Biochemical Pharmacology|July 15, 2018
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cellsElena Mariotto, Roberta Bortolozzi, Ilaria Volpin, et al.
European Journal of Medicinal Chemistry|November 9, 2016
Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agentsDavide Carta, Roberta Bortolozzi, Mattia Sturlese, et al.
Journal of Medicinal Chemistry|September 13, 2013
Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitorsMaria Grazia Ferlin, Davide Carta, Roberta Bortolozzi, et al.
Nuclear Medicine and Biology|October 4, 2016
Melanoma targeting with [<sup>99m</sup>Tc(N)(PNP3)]-labeled α-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical propertiesDavide Carta, Nicola Salvarese, Nicolò Morellato, et al.
Frontiers in Immunology|January 30, 2020
Pyridinecarboxylic Acid Derivative Stimulates Pro-Angiogenic Mediators by PI3K/AKT/mTOR and Inhibits Reactive Nitrogen and Oxygen Species and NF-κB Activation Through a PPARγ-Dependent Pathway in <i>T. cruzi</i>-Infected MacrophagesFederico Nicolás Penas, Davide Carta, Ágata Carolina Cevey, et al.
Amino Acids|December 9, 2015
Radiopharmacological characterization of ⁶⁴Cu-labeled α-MSH analogs for potential use in imaging of malignant melanomaFeng Gao, Wiebke Sihver, Christoph Jurischka, et al.
Analytical Chemistry|July 6, 2011
Method for optimizing coating properties based on an evolutionary algorithm approachDavide Carta, Laura Villanova, Stefano Costacurta, et al.
Frontiers in Immunology|January 10, 2018
Treatment with a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of <i>Trypanosoma cruzi</i>-Infected MiceFederico Nicolás Penas, Davide Carta, Ganna Dmytrenko, et al.
European Journal of Medicinal Chemistry|June 14, 2019
Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinonesRoberta Bortolozzi, Davide Carta, Matteo Dal Prà, et al.
Pageof 3